CME Group Inc.
CME · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $83 | $76 | $60 | $82 |
| - Cash | $3 | $3 | $3 | $3 |
| + Debt | $3 | $3 | $3 | $3 |
| Enterprise Value | $84 | $76 | $61 | $82 |
| Revenue | $6 | $6 | $5 | $5 |
| % Growth | 9.9% | 11.1% | 7% | – |
| Gross Profit | $5 | $5 | $4 | $4 |
| % Margin | 86.1% | 85.1% | 85% | 82.2% |
| EBITDA | $5 | $5 | $4 | $4 |
| % Margin | 82.2% | 83.6% | 80% | 83.7% |
| Net Income | $4 | $3 | $3 | $3 |
| % Margin | 57.5% | 57.8% | 53.6% | 56.2% |
| EPS Diluted | 9.67 | 8.86 | 7.4 | 7.29 |
| % Growth | 9.1% | 19.7% | 1.5% | – |
| Operating Cash Flow | $4 | $3 | $3 | $2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $4 | $3 | $3 | $2 |